BlackRock Fund Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $92K | Buy |
3,499
+104
| +3% | +$2.73K | ﹤0.01% | 3628 |
|
|
2016
Q3 | $137K | Sell |
3,395
-5
| -0.1% | -$202 | ﹤0.01% | 3559 |
|
|
2016
Q2 | $181K | Buy |
3,400
+815
| +32% | +$43.4K | ﹤0.01% | 3484 |
|
|
2016
Q1 | $154K | Sell |
2,585
-192
| -7% | -$11.4K | ﹤0.01% | 3555 |
|
|
2015
Q4 | $269K | Buy |
2,777
+134
| +5% | +$13K | ﹤0.01% | 3421 |
|
|
2015
Q3 | $140K | Sell |
2,643
-70
| -3% | -$3.71K | ﹤0.01% | 3610 |
|
|
2015
Q2 | $216K | Sell |
2,713
-18,500
| -87% | -$1.47M | ﹤0.01% | 3498 |
|
|
2015
Q1 | $1.57M | Buy |
21,213
+1,615
| +8% | +$120K | ﹤0.01% | 3173 |
|
|
2014
Q4 | $3.46M | Buy |
19,598
+2,918
| +17% | +$516K | ﹤0.01% | 3036 |
|
|
2014
Q3 | $3.35M | Buy |
16,680
+431
| +3% | +$86.6K | ﹤0.01% | 2970 |
|
|
2014
Q2 | $3.52M | Buy |
+16,249
| New | +$3.52M | ﹤0.01% | 3017 |
|